|
JRC Publications Repository >
Browsing by Author MORGENSTERN Alfred
Showing results 33 to 52 of 92
| Publication Year | Title | Author(s), Editor(s), Other Contributor(s) | Publication Type | | 2007 | Gemcitabine Radiosensitizes Multiple Myeloma Cells to Low LET, but not High LET, Irradiation | SUPIOT S.; THILLAYS F.; RIO E.; GOUARD S.; MORGENSTERN ALFRED; BRUCHERTSEIFER FRANK; MAHE M. A.; CHATAL J. F.; DAVODEAU F.; CHEREL M. | Articles in Journals |
| 2013 | Half-lives of 221Fr, 217At, 213Bi, 213Po and 209Pb from the 225Ac decay series | SULIMAN GABRIEL; POMME Stefaan; MAROULI Maria; VAN AMMEL Raf; STROH HEIKO; JOBBAGY Viktor; PAEPEN Jan; DIRICAN A.; BRUCHERTSEIFER Frank; APOSTOLIDIS Christos, et al | Articles in Journals |
| 2012 | High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum | RAUCH C; SEIDL C.; SCHLAPSCHY M; SKERRA A; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; SENEKOWITSCH-SCHMIDTKE R. | Articles in Journals |
| 2012 | High-resolution alpha-particle spectrometry of the 230U decay series | MAROULI MARIA; POMME Stefaan; PAEPEN Jan; VAN AMMEL Raf; JOBBAGY VIKTOR; DIRICAN ABDULLAH; SULIMAN GABRIEL; STROH HEIKO; APOSTOLIDIS Christos; ABBAS Kamel, et al | Contributions to Conferences |
| 2010 | Immunoliposomal Delivery of 213Bi for Alpha-emitter Targeting of Metastatic Breast Cancer | LINGAPPA M.; SONG H.; THOMPSON S.; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SGOUROS G. | Articles in Journals |
| 2007 | An Improved Method for the Production of Ac-225/Bi-213 from Th-229 for Targeted Alpha Therapy | ZIELINSKA Barbara; APOSTOLIDIS CHRISTOS; BRUCHERTSEIFER FRANK; MORGENSTERN ALFRED | Articles in Journals |
| 2009 | In vitro and in vivo comparison of 226Th and 213Bi-labelled radioconjugates for target alpha therapy | BRUCHERTSEIFER Frank; MORGENSTERN Alfred; FRIESEN CLAUDIA; ROSCHER MAREIKE; MILTNER E.; PFOST B.; SENEKOWITSCH-SCHMIDTKE R.; ABBAS Kamel; APOSTOLIDIS Christos | Contributions to Conferences |
| 2012 | In vitro evaluation of alpha-particle emitter Ac-225 for somatostatin receptor radiotherapy | GRAF Franziska; MORGENSTERN Alfred; BRUCHERTSEIFER Frank; VENKATACHALAM S.; FOTTNER C.; WEBER M.m.; KAINA B; SCHRECKENBERGER M; MIEDERER Matthias | Contributions to Conferences |
| 2006 | In Vitro Screening for Synergism of High-linear Energy Transfer 213Bi-radiotherapy with other Therapeutic Agents for the Treatment of B-cell Chronic Lymphocytic Leukemia | VANDENBULCKE K.; THIERENS H.; VOS F.d.; OFFNER F.; JANSSENS F.; PHILIPPE J.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; BACHER K.; DE GELDER V., et al | Articles in Journals |
| 2005 | In Vivo and In Vitro Inhibition of Pancreatic Cancer Growth by Targeted Alpha Therapy using 213Bi-CHX.A"-C595 | QU C.f.; SONG Y.j.; RIZVI S.m.a.; SMITH R.m.; PERKINS A.c.; MORGENSTERN ALFRED; BRECHBIEL M.; ALLEN Barry J. | Articles in Journals |
| 2009 | Inhibition ofMicrometastatic Prostate Cancer Cell Spread in Animal Models By 213BilabeledMultipleTargeted Alpha-Radioimmunoconjugates | LI Y.; SONG E.; ABBAS RIZVI S. M.; POWER C. A.; BERETOV J.; RAJA C.; COZZI P. J.; MORGENSTERN Alfred; APOSTOLIDIS Christos; ALLEN B. J., et al | Articles in Journals |
| 2006 | Interaction of Radiolabeled Antibodies with Fungal Cells and Components of Immune System In Vitro and During Radioimmunotherapy of Experimental Fungal Infection | DADACHOVA E.; BRYAN R.a.; APOSTOLIDIS CHRISTOS; MORGENSTERN ALFRED; ZHANG T.; MOADEL T.; CASADEVALL A. | Articles in Journals |
| 2007 | Interim Analysis of Toxicity and Response in Phase 1 Trial of Systemic Targeted Alpha Therapy for Metastatic Melanoma | RAJA C.; GRAHAM P.; ABBAS RIZVI S. M.; SONG E.; GOLDSMITH H.; THOMPSON J.; BOSSERHOFF A.; MORGENSTERN ALFRED; APOSTOLIDIS CHRISTOS; KEARSLEY J., et al | Articles in Journals |
| 2005 | Intralesional Targeted Alpha Therapy for Metastatic Melanoma | ALLEN Barry J.; RAJA C.; RIZVI S.m.a.; LI Y.; TSUI W.; GRAHAM P.; THOMPSON J.; REISFELD R.a.; KEARSLEY J.; MORGENSTERN ALFRED, et al | Articles in Journals |
| 2009 | Intravesical a-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice | PFOST Birgit; SEIDI Christof; AUTENRIETH Michael; SAUR Dieter; BRUCHERTSEIFER Frank; MORGENSTERN Alfred; SCHWAIGER Markus; SENEKOWITSCH-SCHMIDTKE Reingard | Articles in Journals |
| 2010 | Investigation of Para-sulfonatocalix[n]arenes [n = 6, 8] as Potential Chelates for 230U | MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred | Articles in Journals |
| 2010 | Investigation of para-sulfonatocalix[n]arenes [n = 6, 8] as potential chelates for 230U† | MONTAVON Gilles; REPINC Urska; APOSTOLIDIS Christos; BRUCHERTSEIFER Frank; ABBAS Kamel; MORGENSTERN Alfred | Articles in Journals |
| 2012 | Is DTPA a good competing chelating agent for Th(IV) in human serum and suitable in targeted alpha therapy? | LE DU Alicia; SABATIE-GEGOVA Andrea; MORGENSTERN Alfred; MONTAVON Gilles | Articles in Journals |
| 2011 | Magnetic Memory Effect in a Transuranic Mononuclear Complex | MAGNANI Nicola; APOSTOLIDIS Christos; MORGENSTERN Alfred; COLINEAU Eric; GRIVEAU Jean-Christophe; BOLVIN Hélène; WALTER OLAF; CACIUFFO Roberto | Articles in Journals |
| 2011 | Magnetic Memory Effect in a Transuranic Mononuclear Complex | MAGNANI Nicola; APOSTOLIDIS Christos; MORGENSTERN Alfred; COLINEAU Eric; GRIVEAU Jean-Christophe; WALTER Olaf; CACIUFFO Roberto | Articles in Journals |
Showing results 33 to 52 of 92
|
